Ticker brief

ARMP ARMATA PHARMACEUTICALS INC

Consumer, Non-cyclical · Pharmaceuticals

last close
$3.64
1 day
+5.5%
14 days
+0.3%
mkt cap
·
signals 14d
14
authors 14d
3
crowd 14d
+0.22
Sentiment — last 14 days
daily mean sentiment, 2026-10-07 → 2026-10-13 · now +0.38 (−1 bearish … +1 bullish)
Who spoke3
authorgradetrader scoresignalsmean sent
@beach_tradesC-2.9712+0.25
@PrismMarketViewC·1+0.20
@PrismDMA-2.761+0.15
Recent signals14of 14 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-10-13@beach_trades+0.35Briefly links ARMP to the Department of War and Phase 3 development.+17.4%
2026-10-13@beach_trades+0.25Context-dependent correction links ARMP to the Department of War.+17.4%
2026-10-13@beach_trades+0.55Author discloses a losing ARMP long and cites defense ties, pipeline, patents, and management credentials.+17.4%
2026-10-12@beach_trades+0.45Suggests ARMP may eventually emerge as one of very few speculative plays.+0.3%
2026-10-12@beach_trades+0.30Briefly frames ARMP as a bio-defense company connected with the DoD.+0.3%
2026-10-12@beach_trades+0.25Invites readers to examine ARMP, expressing mild constructive interest without a trade.+0.3%
2026-10-12@beach_trades+0.00Points to ARMP's CEO discussing a Russia plague scare; the linked statement itself is unavailable.+0.3%
2026-10-11@beach_trades-0.20Associates ARMP with pneumonic plague, implying negative concern, but context is thin.+0.3%
2026-10-11@beach_trades+0.30Suggests ARMP technology may address a Russian plague-related biodefense need.+0.3%
2026-10-11@beach_trades+0.20Describes ARMP phage-cocktail candidates and their targeted pulmonary indications.+0.3%
2026-10-10@beach_trades+0.20Associates ARMP with the bio-defense theme without a trade instruction.+0.3%
2026-10-08@beach_trades+0.35Floats ARMP as a possible plague-related play but conditions the view on further diligence.-5.7%
2026-10-07@PrismDM+0.15Armata announces two issued US patents and a planned second-half 2026 Phase 3 program.-4.5%
2026-10-07@PrismMarketView+0.20Armata received two U.S. patents and plans a Phase 3 study in H2 2026.-4.5%

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.